Baxter
BAX
#872
Rank
$21.33 B
Marketcap
$42.01
Share price
-0.52%
Change (1 day)
2.44%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - P/B ratio

P/B ratio as of February 2024 : 2.61

According to Baxter's latest financial reports the company has a price-to-book ratio of 2.61.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Baxter - P/B ratio (from 2001 to 2022)

P/B ratio by year

Year P/B ratio Change
2022-12-314.36-7.5%
2021-12-314.710.32%
2020-12-314.70-12.19%
2019-12-315.3523.83%
2018-12-314.3211.82%
2017-12-313.8632.64%
2016-12-312.9123.59%
2015-12-312.36-51.64%
2014-12-314.879.51%
2013-12-314.45-14.7%
2012-12-315.2227.7%
2011-12-314.09-5.54%
2010-12-314.33-8.99%
2009-12-314.75-10.92%
2008-12-315.340.2%
2007-12-315.3310.68%
2006-12-314.81-12.09%
2005-12-315.47-5%
2004-12-315.762.1%
2003-12-315.64-1.22%
2002-12-315.71

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
2.19-16.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
4.76 82.33%๐Ÿ‡บ๐Ÿ‡ธ USA
2.73 4.44%๐Ÿ‡บ๐Ÿ‡ธ USA
5.12 95.93%๐Ÿ‡บ๐Ÿ‡ธ USA
7.50 187.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-7.47-385.84%๐Ÿ‡บ๐Ÿ‡ธ USA
1.18-54.67%๐Ÿ‡บ๐Ÿ‡ธ USA
20.2 673.82%๐Ÿ‡บ๐Ÿ‡ธ USA
2.00-23.30%๐Ÿ‡บ๐Ÿ‡ธ USA